Cargando…

Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer

Nearly 70% of adults in the US are currently overweight or obese. Despite such high prevalence, the impact of obesity on antitumor immunity and immunotherapy outcomes remains incompletely understood, particularly in patients with breast cancer. Here, we addressed these gaps in knowledge using two mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibson, Justin T., Orlandella, Rachael M., Turbitt, William J., Behring, Michael, Manne, Upender, Sorge, Robert E., Norian, Lyse A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573510/ https://www.ncbi.nlm.nih.gov/pubmed/33123173 http://dx.doi.org/10.3389/fimmu.2020.590794

Ejemplares similares

Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
por: Turbitt, William J., et al.
Publicado: (2021)

The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer
por: Orlandella, Rachael M., et al.
Publicado: (2020)

Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics
por: Turbitt, William J., et al.
Publicado: (2019)

Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
por: Lesokhin, Alexander M., et al.
Publicado: (2013)

Obesity diminishes response to PD-1-based immunotherapies in renal cancer
por: Boi, Shannon K, et al.
Publicado: (2020)

Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?
por: Farag, Kristine I., et al.
Publicado: (2021)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
por: Wang, Yufei, et al.
Publicado: (2020)

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
por: Hao, Zhaonian, et al.
Publicado: (2021)

Rapid Maturation of Effector T Cells in Tumors, but Not Lymphoid Organs, during Tumor Regression
por: Norian, Lyse A., et al.
Publicado: (2007)

Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
por: Hao, Zhaonian, et al.
Publicado: (2022)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
por: Wu, Yuze, et al.
Publicado: (2022)

Synergistic Induction of Apoptosis in Primary B-CLL Cells after Treatment with Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Histone Deacetylase Inhibitors
por: Norian, Lyse A., et al.
Publicado: (2009)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy
por: Beyranvand Nejad, Elham, et al.
Publicado: (2020)

Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
por: Zhang, Bin, et al.
Publicado: (2013)

Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?
por: Escors, David, et al.
Publicado: (2013)

Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immunotherapy
por: Norian, Lyse A., et al.
Publicado: (2012)

CD115(−) monocytic myeloid-derived suppressor cells are precursors of OLFM4(high) polymorphonuclear myeloid-derived suppressor cells
por: Zou, Yunyun, et al.
Publicado: (2023)

Eugenol triggers CD11b(+)Gr1(+) myeloid-derived suppressor cell apoptosis via endogenous apoptosis pathway
por: Ding, Ying, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
por: Shi, Houhui, et al.
Publicado: (2021)

Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
por: Joshi, Shweta, et al.
Publicado: (2022)

Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
por: Draghiciu, Oana, et al.
Publicado: (2015)

Role of myeloid-derived suppressor cells in the promotion and immunotherapy of colitis-associated cancer
por: Wang, Yungang, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the Effect of Maintenance Immunotherapy
por: Iglesias-Escudero, María, et al.
Publicado: (2020)

Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy
por: Wang, Yan, et al.
Publicado: (2022)

Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells
por: Qin, Guohui, et al.
Publicado: (2023)

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond
por: Zhao, Yang, et al.
Publicado: (2023)

MTHFD1L, A Folate Cycle Enzyme, Is Involved in Progression of Colorectal Cancer()()
por: Agarwal, Sumit, et al.
Publicado: (2019)

Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
por: Toh, Benjamin, et al.
Publicado: (2011)

Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy
por: He, Wei, et al.
Publicado: (2016)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma
por: Behring, Michael, et al.
Publicado: (2018)

Meta-analysis of the robustness of COVID-19 diagnostic kit performance during the early pandemic
por: Shanmugam, Chandrakumar, et al.
Publicado: (2022)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy
por: Cook, Katherine W, et al.
Publicado: (2021)

Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy
por: Adeshakin, Adeleye O., et al.
Publicado: (2022)

Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
por: Zalfa, Cristina, et al.
Publicado: (2021)

Dendritic cells inhibit myeloid-derived suppressor cells infiltration and function in mouse B16 melanoma microenvironment
por: Xia, Siyuan, et al.
Publicado: (2013)

Hydroxychloroquine induces apoptosis of myeloid-derived suppressor cells via up-regulation of CD81 contributing to alleviate lupus symptoms
por: Ni, Jiali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c6in9kthh3thsuqempf31vn3ln